-
公开(公告)号:US20180037869A1
公开(公告)日:2018-02-08
申请号:US15554849
申请日:2016-03-04
Inventor: Hae Young Suh , Sung Soo Kim , Da Young Chang , Jin Hwa Jung , Young Don Lee , Woo Sup Hwang , Jin Sung Park , Su Jung Lee
IPC: C12N5/0775 , A61K31/513 , A61K45/06 , A61K35/28
CPC classification number: C12N5/0665 , A61K31/4188 , A61K31/4745 , A61K31/506 , A61K31/513 , A61K31/675 , A61K31/704 , A61K33/24 , A61K35/12 , A61K35/28 , A61K45/06 , C12N5/0663 , C12N2501/73 , C12N2510/00 , C12N2523/00
Abstract: The present disclosure relates to a method for preparing cells for cancer treatment and a kit for cancer treatment comprising cells prepared by the method. The preparation method of the present disclosure can provide F cells, which, in spite of having no difference in the proliferative capacity compared with mesenchymal stem cells expressing cytosine deaminase that are harvested and used immediately after the culture, exhibit a very excellent tumor suppressive effect through the treatment together with 5-FC and induce a remarkable synergistic effect exceeding an effect from combinative treatment with an existing anticancer drug in cases of a combinative treatment with another anticancer drug. Therefore, the present disclosure can be utilized for a kit for cancer treatment comprising such F cells, and thus can be favorably used to maximize the effect of existing cancer treatments.